ArticlePDF Available

Variation in thyroid hormone levels among children in Benghazi city -Libya

Authors:

Abstract

Thyroid hormones play a vital part in development, of metabolism, nervous system myelination, and organ functions. Thyroid complaints can be tough to identify clinically, but thyroid function tests can assist in making a diagnosis. Evaluating thyroid stimulating hormone is the major step. If it is abnormal, free thyroxin should be measured. An elevated concentration of thyroid stimulating hormone with a low concentration of free thyroxin suggests hypothyroidism. A low concentration of thyroid stimulating hormone with a great concentration of free thyroxin suggests hyperthyroidism. A cross sectional study was done in children attending to Pediatric hospital- Benghazi for one year from January 2018 to December 2018. Total of 221 children, 94 (43%) were males and 127 (57%) were females attending the hospital for thyroid hormone test were included in the study. Secondary data on gender, TSH, T3 and T4 level were analyzed. Thyroid diseases reported was found to be more prevalent in females than males. T4 was higher in females than males by percentage 8 (4%) to 5 (2%) respectively. TSH was also has a higher rate recorded in females than males by percentage 38 (17%) to 28 (13%) respectively. It can be concluded from the present study that the gender has a significant effect on the levels T4, T3 and TSH. Initial analysis and treatment are important to avoid irreparable and enduring nervous system injury and progressive interruption, specifically in newborns as they are very in danger to thyroid dysfunction.
International Journal of Multidisciplinary Sciences and Advanced Technology Special Issue 1(2021) 294298
294
International Journal of Multidisciplinary Sciences
and Advanced Technology
Journal home page: http://www.ijmsat.com
Variation in thyroid hormone levels among children in Benghazi
city - Libya
Noor-alhooda Milood Al-awkally1, Maree Dokally Ali2, Alreda Miloud Al-awkally3,
Nesrine Miloud Al-awkally4, Abeer Miloud Al-awkally5, Dareen El shareef
Jadullah6, 7Muftah abdulwahed Nasib7 and Khadija Saeed Ali Ghafir8
1- Medical Laboratory Department, High institutes for comprehensive professions, Suluq, Libya
2- Medical Laboratory Department, High institutes for comprehensive professions- Suluq, Libya
3- Central Pharmacy Department, Ministry of health, Darna, Libya
4- Surgery Department, Al- haowari Hospital- Benghazi
5- Livestock and Marine Department, Ministry of Agriculture, Livestock and Marine, Darna, Libya
6- Faculty of pharmacy- Benghazi University- Libya
7- Microbiology Department, Science Faculty, Omar Almukhtar University, Libya
8- Faculty of Natural Resources and Environmental Science, Omar Almukhtar University, Libya
Email: noornooor1973@gmail.com
Received 15February 2021, Accepted 10March 2021, Available online 30 March 2021
1. Introduction
The thyroid is a butterfly-shaped endocrine gland usually located in the lower front of the neck below the larynx and
develops from two embryological structures. The thyroid's job is which are secreted thyroxin (T4) and triiodothyronine
(T3) into the blood and then carried to every tissue in the body to helps the body use energy, stay warm and keep the
ABSTRACT
Thyroid hormones play a vital part in development, of metabolism, nervous system myelination, and organ functions.
Thyroid complaints can be tough to identify clinically, but thyroid function tests can assist in making a diagnosis.
Evaluating thyroid stimulating hormone is the major step. If it is abnormal, free thyroxin should be measured. An
elevated concentration of thyroid stimulating hormone with a low concentration of free thyroxin suggests
hypothyroidism. A low concentration of thyroid stimulating hormone with a great concentration of free thyroxin
suggests hyperthyroidism. A cross sectional study was done in children attending to Pediatric hospital- Benghazi for
one year from January 2018 to December 2018. Total of 221 children, 94 (43%) were males and 127 (57%) were
females attending the hospital for thyroid hormone test were included in the study. Secondary data on gender, TSH, T3
and T4 level were analyzed. Thyroid diseases reported was found to be more prevalent in females than males. T4 was
higher in females than males by percentage 8 (4%) to 5 (2%) respectively. TSH was also has a higher rate recorded in
females than males by percentage 38 (17%) to 28 (13%) respectively. It can be concluded from the present study that
the gender has a significant effect on the levels T4, T3 and TSH. Initial analysis and treatment are important to avoid
irreparable and enduring nervous system injury and progressive interruption, specifically in newborns as they are very
in danger to thyroid dysfunction.
Keywords: Hypothyroidism, Hyperthyroidism, children hospital, Benghazi.
Original article
Noor-alhooda Milood Al-awkally et al / International Journal of Multidisciplinary Sciences and Advanced Technology Special Issue 1 (2021) 294298
295
brain, heart, muscles and other organs working as they should. However, most of the T3 in the blood is made from T4
in other body tissues.[1, 4] Conditions affecting thyroid function may cause temporary and permanent nervous system
injury and developmental delay.[2] Hypothyroidism occurs when the thyroid becomes damaged or swollen, making it
incapable to produce sufficient of the thyroid hormone thyroxin. One in 2,500 newborns has hypothyroidism at birth,
while approximately 1 in 500 school-age children has hypothyroidism and a raised TSH and a low free T4 indicate
primary hypothyroidism.[4, 15] Routine tests will generally detect hypothyroidism in newborns.[5] And newborns often do
not show symptoms at birth. Some common signs and symptoms of hypothyroidism in older children may include
fatigue, Constipation, feeling cold all over, puffy face, weight gain from fluid retention, dry or yellow skin, loss of hair,
or hair becoming coarse, loice becoming hoarse, goiter, delayed reflexes and muscular pain oddly needs but is not
producing, [3] it can change TSH levels and possibly cause symptoms. Treatment generally means a medication that
replaces the thyroid hormones your child’s.[5] This is the reverse of hyperthyroidism, a low TSH and raised free T4
indicate hyperthyroidism that is occurs due to an inappropriately high synthesis and secretion of thyroid hormone (TH)
by the thyroid.[7] Hyperthyroidism is relatively rare in children (yearly incidence of 8 per 1,000,000 children less than
15 years old and 1 per 1,000,000 children less than 4 years old). The most frequent causes are Graves’ disease (GD) and
toxic nodular goiter. GD is the most prevalent cause of hyperthyroidism in iodine replete geographical areas, with 20
30 annual cases per 100,000 individuals.[11] GD occurs more often in women and has a population prevalence of 1
1.5%. Approximately 3% of women and 0.5% of men develop GD during their lifetime.[12] The peak incidence of GD
occurs among patients aged 3060 years, with an increased incidence among African Americans.[13] The complications
of untreated hyperthyroidism include weight loss, osteoporosis, fragility fractures, atrial fibrillation, embolic events, and
cardiovascular dysfunction.[8,9] Graves’ hyperthyroidism is treated by decreasing thyroid hormone synthesis with the use
of ATD, or by reducing the amount of thyroid tissue with radioactive iodine (RAI) treatment or total thyroidectomy.
Patients with newly diagnosed Graves’ hyperthyroidism are usually medically treated for 12–18 months with
methimazole (MMI) as the preferred drug. Patients with persistently high TSH-R-Ab at 1218 months can continue
MMI treatment.[10] TSH is produced by the pituitary if it senses that the thyroid is not releasing enough thyroxin. A
healthy thyroid receives the message and responds by producing more thyroxin. This helps to keep your hormone levels
within a normal range. A TSH test can help determine if the thyroid is failing, and if it may be hypothyroidism. It is
recognized as the most reliable test of its kind.[6] TSH may remain suppressed for weeks or even months after a patient
starts antithyroid medications. It is useful to monitor free T4 and free T3 every 612 weeks to judge the adequacy of
treatment. A rise in TSH indicates overtreatment.[14] Study was aimed to detect the different features of disorders with
hypothyroidism and hyperthyroidism in childhood and impact of gender on the T4, T3 and TSH levels in children
pediatric hospitals-Benghazi.
2. Material and Methods
Study setting:
In a cross sectional study the serum concentrations of T4, T3 and TSH were measured in 221childern was done in
children attended to Pediatric hospital- Benghazi for one year from January 2018 to December 2018. Total 221 children
had attended the pediatric hospital for thyroid hormone test were included in the study. Secondary data on gender, TSH,
T3 and T4 level were analyzed.
Collection of blood sample: Blood samples were obtained and collected in plain tube. Serum was separated by
centrifugation at 2000 rpm for 5 minutes and stored in a freezer at -20 ºC.
Determination of hormones: The samples were analyzed for T3, T4 and TSH by Cobas 411.
Statistical analysis: - Analysis was done by the standard deviation function is STDEV, and the test uses is T- test.
3. Results
4. Distribution of the cases according to the gender.
Of 221 patients, Males were found to be 94 (43%) and females were 127(57%) respectively.
Noor-alhooda Milood Al-awkally et al / International Journal of Multidisciplinary Sciences and Advanced Technology Special Issue 1 (2021) 294298
296
Figure. 1: Distribution of the cases according to the gender.
4.1 Distribution of the cases during the seasons.
The data indicated that number of the patients were lowest in the winter (44%) while highest in summer (57%).
Table1: Distribution of the children during the seasons.
Seasons
Winter
Spring
Summer
Autumn
Children
44 (20%)
52 (24%)
125 (57%)
0 (0%)
4.2Comparison between the gender according to high level of T3, T4 and TSH hormones.
According to TSH, high level was more observed in females than males by 38 (17%) to 28 (13%) respectively.
4.3 Comparison between T3, T4 and TSH levels between the cases.
According to the levels of the hormones, the lowest level of T3 was 4 (2%), while T4 level was 9 (4%) and TSH level
was 8 (4%). Also the normal level of hormone in the children, T3 was with normal level in 173 (78%) child, while T4
was normal in187 (85%) child and TSH in 152 (69%) child. The highest level of the hormone, 58 (26%) child had a
high level of T3, while T4 in 9 (4%) child and TSH in 58 (26%) child.
Table 2: Comparison between T3, T4 and TSH levels between the cases
Hormone Level
T3
(0.95-2.5 (ηmol/L))
T4
(60-180 (ηmol/L))
TSH
(0.27-4.70μU/L)
Level of less than
normal range
4 (2%)
9 (4%)
8 (4%)
Normal level
173 (78%)
187 (85%)
152 (69%)
Level of more than
normal range
33 (15%)
4 (2%)
58 (26%)
Not available/
11 (5%)
21 (10%)
2 (1%)
4.4 Comparison of the sexes according to abnormal levels of T3, T4 and TSH hormones.
The ratio of the sexes was close to the rate of T3 hormone, where the ratio of females to males was 19 (9%) to
18 (8%) respectively. T4 was higher in females than males by percentage 8 (4%) to 5 (2%) respectively. TSH was also
has a higher rate recorded in females than males in the rate of 38 (17%) to 28 (13%) respectively.
Table 3: Comparison of the sexes according to abnormal levels of T3, T4 and TSH hormones.
Gender
High level of
T3
High level of
T4
High level of
TSH
Male
18 (8%)
5 (2%)
28 (13%)
Female
19 (9%)
8 (4%)
38 (17%)
43%
57%
Male
Female
Noor-alhooda Milood Al-awkally et al / International Journal of Multidisciplinary Sciences and Advanced Technology Special Issue 1 (2021) 294298
297
5. Discussion
The pituitary cells link with your thyroid by distribution their specific hormone, TSH into the blood. When
your T4 levels are at your set point, the pituitary gland sends out abundant TSH to say the thyroid to retain production
the similar quantity of T4. If the T4 levels become low, the pituitary sends out extra TSH to tell the thyroid to create
extra T4. The lesser the T4 levels go, the higher the TSH goes. The contrary is also right: if the T4 levels become too
high, the pituitary sends out fewer TSH, telling the thyroid to create fewer T4. The normal hormonal levels are different
for different genders.[18] We found the prevalence of thyroid diseases reported was found to be more prevalent in
females than males, that agree with many studies, thyroid disease in general and hypothyroidism in particular are very
common in women [16, 17]. Studies that worked on the effect of sex on thyroid function, where they concluded that the
level of T4, it was higher in females than males. [19, 20]. It can be concluded from the present study that the gender has
a significant effect on the levels T4, T3 and TSH.
6. Conclusion
The increase of district characteristics of thyroid function and dysfunction in childhood is requiring Pediatric
medical care. Early diagnosis and treatment are needed to avoid irreversible and permanent nervous system injury and
developmental delay, especially in newborns as they are very in danger to thyroid dysfunction. It can be concluded from
the present study that the gender has a significant effect on the levels T4, T3 and TSH.
7. Acknowledgment
Above all, praise is to ALLAH Almighty, The Merciful, may anything in our life bring us closer to Him. We
wish to express our deepest appreciation and gratefulness to all staff of Pediatric laboratory who gave us the opportunity
to provide ours research all information's by and working with easily.
8. References
1- Larsen PR, Davis TF, Hay ID. (1998). The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR,
eds. Williams textbook of endocrinology. Philadelphia: Saunders; 389 515.
2- Gillam MP, Kopp P. (2001) Genetic regulation of thyroid development. Curr Opin Pediatr.13:358363.
3- Debra Counts, Surendra K. (2009). Varma.Hypothyroidism in Children Pediatrics in Review July Volum 30 / Issue 7.
4- LaFranchi S. (2002). Acquired hypothyroidism. In: Feinberg L, Kleinman RE, eds.
Saunders Manual of Pediatric Practice. 2nd ed. Philadelphia, PA:Saunders.
5- The endocrine System Part XXV. (2007). In Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson
Textbook of Pediatrics. 18th ed. Philadelphia, PA:Saunders Elsevier.
6- Li J, Thompson TD, Miller JW, et al. (2008). Cancer incidence among children and adolescents in the United States,
2001-2003. Pediatrics. 121:e1470-e1477.
7- Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM,
Rivkees SA, Ross DS, Sosa JA, Stan MN. (2011). American Thyroid Association; American Association of Clinical
Endocrinologists: Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American
Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17:456520.
8- Bartalena L. (2013). Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol 9:724
734.
9- Biondi B, Kahaly GJ. (2010). Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat
Rev Endocrinol 6: 431443.
10- George J. Kahalya Luigi Bartalenab Lazlo Hegedüsc Laurence Leenhardtd Kris Poppee Simon H. Pearcef. (2018).
European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J 7:167
186; DOI: 10.1159/000490384.
11- Smith TJ, Hegedus L.(2016). Graves’ disease. N Engl J Med 375:15521565.
12- Nystrom HF, Jansson S, Berg G. (2013). Incidence rate and clinical features of hyperthyroidism in a long-term
iodine sufficient area of Sweden (Gothenburg) 20032005. Clin Endocrinol 78:768776.
Noor-alhooda Milood Al-awkally et al / International Journal of Multidisciplinary Sciences and Advanced Technology Special Issue 1 (2021) 294298
298
13- McLeod DS, Caturegli P, Cooper DS, Matos PG, Hutfless S. (2014). Variation in rates of autoimmune thyroid
disease by race/ethnicity in US military personnel. JAMA 311:1563 1565.
14- G. Papi, E. D. Uberti, C. Betterle, et al. (2007). Subclinical hypothyroidism,” Current Opinion in Endocrinology,
Diabetes and Obesity, vol. 14, no. 3, pp. 197208.
15- Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O'Leary P. (2010). Thyrotropin and thyroid antibodies
as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current
immunoassay techniques. J Clin Endocrinol Metab 95:1095-104.
16- Y. A. Abdulmughni, M. A. Al-Hureibi, K. A. Al-Hureibi, M. A. Ghafoor, A. H. Al-Wadan, Y. A. Al-Hureibi.
(2004). Thyroid cancer in Yemen. Saudi Medical Journal. 25 (1): Pages 55-59.
17- L. Wartofsky, D. V. Nostrand, K. D. Burman. (2006). Overt and subclinical hypothyroidism in women. Surgery
Obstetrics and Gynecology. 61 (8): pages 535-542.
18- M. A. Razzak. (1992). Effect of Age and Sex on Thyroid Function Tests. Establishment of norms for the Egyptian
Population in Developments in Radioimmunoassay and Related Procedures International Atomic Energy Agency.
p.3538.
19- S. Muslim, Z. Khalil. (2000). Effect of Age, Sex, Salt, Water and Climate on T3, T4 and TSH in Healthy
Individuals, Department of Zoology Peshawar University.
20- J. A . Franklyn, B. D. Ramsden, M. C. Sheppard. (1985). The influence of age and sex on tests of thyroid function.
Am Clin Biochem 1985;22:5025.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Graves' disease (GD) is a systemic autoimmune disorder characterized by the infiltration of thyroid antigen-specific T cells into thyroid-stimulating hormone receptor (TSH-R)-expressing tissues. Stimulatory autoantibodies (Ab) in GD activate the TSH-R leading to thyroid hyperplasia and unregulated thyroid hormone production and secretion. Diagnosis of GD is straightforward in a patient with biochemically confirmed thyrotoxicosis, positive TSH-R-Ab, a hypervascular and hypoechoic thyroid gland (ultrasound), and associated orbitopathy. In GD, measurement of TSH-R-Ab is recommended for an accurate diagnosis/differential diagnosis, prior to stopping antithyroid drug (ATD) treatment and during pregnancy. Graves' hyperthyroidism is treated by decreasing thyroid hormone synthesis with the use of ATD, or by reducing the amount of thyroid tissue with radioactive iodine (RAI) treatment or total thyroidectomy. Patients with newly diagnosed Graves' hyperthyroidism are usually medically treated for 12-18 months with methimazole (MMI) as the preferred drug. In children with GD, a 24- to 36-month course of MMI is recommended. Patients with persistently high TSH-R-Ab at 12-18 months can continue MMI treatment, repeating the TSH-R-Ab measurement after an additional 12 months, or opt for therapy with RAI or thyroidectomy. Women treated with MMI should be switched to propylthiouracil when planning pregnancy and during the first trimester of pregnancy. If a patient relapses after completing a course of ATD, definitive treatment is recommended; however, continued long-term low-dose MMI can be considered. Thyroidectomy should be performed by an experienced high-volume thyroid surgeon. RAI is contraindicated in Graves' patients with active/severe orbitopathy, and steroid prophylaxis is warranted in Graves' patients with mild/active orbitopathy receiving RAI. © 2018 European Thyroid Association Published by S. Karger AG, Basel.
Article
Corresponding Author: Donald S. A. McLeod, FRACP, MPH, QIMR Berghofer Medical Research Institute, QIMR Locked Bag 2000, Royal Brisbane Hospital, Queensland, Herston, Australia 4029 (donald.mcleod@qimrberghofer.edu.au). Author Contributions: Dr McLeod had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: All authors. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: McLeod, Matos, Hutfless. Critical revision of the manuscript for important intellectual content: McLeod, Caturegli, Cooper, Hutfless. Statistical analysis: McLeod, Matos, Hutfless. Administrative, technical, or material support: Cooper, Matos. Study supervision: Cooper, Hutfless. Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Cooper reported receiving royalties for serving as an editor to Up-to-Date. No other disclosures were reported. Funding/Support: A Cancer Council Queensland PhD scholarship helped support Dr McLeod. Role of the Sponsor: The Cancer Council Queensland had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Additional Contributions: We thank Angie Eick-Cost, PhD (Armed Forces Health Surveillance Center), for her assistance in compiling the data for this study; and Monica Vladut-Talor, MSc, and Noel R. Rose, MD, PhD (both with the Department of Pathology, Johns Hopkins University School of Medicine), and Paul W. Ladenson, MD (Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine), for their contributions to the manuscript. No compensation was received by any of the acknowledged individuals.
Article
Graves disease is an autoimmune disorder characterized by goitre, hyperthyroidism and, in 25% of patients, Graves ophthalmopathy. The hyperthyroidism is caused by thyroid hypertrophy and stimulation of function, resulting from interaction of anti-TSH-receptor antibodies (TRAb) with the TSH receptor on thyroid follicular cells. Measurements of serum levels of TRAb and thyroid ultrasonography represent the most important diagnostic tests for Graves disease. Management of the condition currently relies on antithyroid drugs, which mainly inhibit thyroid hormone synthesis, or ablative treatments ((131)I-radiotherapy or thyroidectomy) that remove or decrease thyroid tissue. None of these treatments targets the disease process, and patients with treated Graves disease consequently experience either a high rate of recurrence, if receiving antithyroid drugs, or lifelong hypothyroidism, after ablative therapy. Geographical differences in the use of these therapies exist, partially owing to the availability of skilled thyroid surgeons and suitable nuclear medicine units. Novel agents that might act on the disease process are currently under evaluation in preclinical or clinical studies, but evidence of their efficacy and safety is lacking.
Article
Objectives: To study hyperthyroidism in long-term iodine sufficiency (IS), as iodine supply affects its occurrence. Design: Prospective descriptive study. Patients: In 2003-2005, all referred cases of subclinical (SH) and overt hyperthyroidism (OH) were registered at diagnosis from a population (n = 631 239) in Gothenburg, Sweden. Measurements: Information on age, gender, smoking, thyroid associated ophthalmopathy (TAO), thyroid hormones and TSH receptor antibodies (TRab) was collected. Incidences were calculated. SH and OH cases with Graves' disease (GD), toxic multinodular goiter (TMNG) and solitary toxic adenoma (STA) were compared. In GD, TRab+ and TRab- cases and patients with (TAO+) and without TAO (TAO-) were compared. Results: The total incidence (n/100 000/year) of hyperthyroidism was 27·6; OH 23·8; SH 3·8; GD 21·4; TMNG 4·3; and STA 1·8. SH was more common among TMNG (40·2%) and STA (45·7%) than in GD (5·9%). SH-GD patients were older, more often smokers and had lower TRab levels than OH-GD patients. FreeT4 and T3 levels in GD were higher than in TMNG and STA. FreeT4, T3 and TRab decreased with age in patients with GD, P < 0·0001. TRab- patients had lower T3 than TRab+ patients, P < 0·001. TRab was positively correlated to FreeT4, P < 0·0001. TAO occurred in 20% of patients with GD. TAO+ patients were younger than TAO- patients. Smokers did not have more TAO. Conclusion: The total incidence of hyperthyroidism was low. GD dominated with an age-related decline of thyroid hormones and TRab levels. The spectrum of hyperthyroidism in this long-term IS area may represent the future situation for countries with shorter history of IS.
Article
Various clinical disorders can cause hyperthyroidism, the effects of which vary according to the patient's age, severity of clinical presentation and association with other comorbidities. Hyperthyroidism is associated with increased morbidity and mortality from cardiovascular disease, although whether the risk of specific cardiovascular complications is related to the etiology of hyperthyroidism is unknown. This article will focus on patients with Graves disease, toxic adenoma and toxic multinodular goiter, and will compare the cardiovascular risks associated with these diseases. Patients with toxic multinodular goiter have a higher cardiovascular risk than do patients with Graves disease, although cardiovascular complications in both groups are differentially influenced by the patient's age and the cause of hyperthyroidism. Atrial fibrillation, atrial enlargement and congestive heart failure are important cardiac complications of hyperthyroidism and are prevalent in patients aged > or = 60 years with toxic multinodular goiter, particularly in those with underlying cardiac disease. An increased risk of stroke is common in patients > 65 years of age with atrial fibrillation. Graves disease is linked with autoimmune complications, such as cardiac valve involvement, pulmonary arterial hypertension and specific cardiomyopathy. Consequently, the etiology of hyperthyroidism must be established to enable correct treatment of the disease and the cardiovascular complications.
Article
Context: Longitudinal studies of risk factors for hypothyroidism are required to inform debate regarding the TSH reference range. There are limited longitudinal data on the predictive value of thyroid antibodies measured by automated immunoassay (as opposed to semiquantitative methods). Methods: We measured TSH, free T(4), thyroid peroxidase antibodies (TPOAbs), and thyroglobulin antibodies (TgAbs) using the Immulite platform on sera from 1184 participants in the 1981 and 1994 Busselton Health Surveys. Outcome measures at follow-up were hypothyroidism, defined as TSH greater than 4.0 mU/liter or on thyroxine treatment; and overt hypothyroidism, defined as TSH above 10.0 mU/liter or on thyroxine treatment. Receiver-operator characteristic analysis was used to determine optimal cutoffs for baseline TSH, TPOAbs, and TgAbs as predictors of hypothyroidism. Results: At 13 yr follow-up, 110 subjects (84 women) had hypothyroidism, of whom 42 (38 women) had overt hypothyroidism. Optimal cutoffs for predicting hypothyroidism were baseline TSH above 2.5 mU/liter, TPOAbs above 29 kIU/liter, and TgAbs above 22 kIU/liter, compared with reference range upper limits of 4.0 mU/liter, 35 kIU/liter, and 55 kIU/liter, respectively. In women with positive thyroid antibodies (TPOAbs or TgAbs), the prevalence of hypothyroidism at follow-up (with 95% confidence intervals) was 12.0% (3.0-21.0%) when baseline TSH was 2.5 mU/liter or less, 55.2% (37.1-73.3%) for TSH between 2.5 and 4.0 mU/liter, and 85.7% (74.1-97.3%) for TSH above 4.0 mU/liter. Conclusions: The use of TSH cutoffs of 2.5 and 4.0 mU/liter, combined with thyroid antibodies, provides a clinically useful estimate of the long-term risk of hypothyroidism.
Article
Chronic lymphocytic thyroiditis or Hashimoto's thyroiditis is the most common childhood cause of goiter and hypothyroidism in iodine-sufficient geographic regions.
Article
Serum concentrations of total thyroid hormones, thyroid hormone binding proteins, free thyroid hormones and thyroid stimulating hormone (TSH) were measured in a large group of healthy normal subjects ( n = 218) to determine the influence of age and sex on tests of thyroid function. No effect of age on measurements of total thyroxine (T4), total triiodothyronine (T3) or reverse T3 was evident. Concentrations of free T4, free T3 and TSH were similarly unaffected, suggesting that increasing age alone does not significantly influence thyroid hormone measurements. There was, however, a rise in thyroxine-binding globulin (TBG) concentration with increasing age and a fall in thyroxine-binding prealbumin (TBPA). An influence of sex on tests of thyroid function was clearly evident. Levels of total T4, total T3, free T4 and the T4: TBG ratio were lower in women between 16 and 49 years than in men, despite an increase in TBG. Lower levels of free T3 were confined to the group of women aged 16–29 years. TSH values were unaffected by sex. These results suggest that sex hormone status in the pre-menopausal female subject may result in an increase in TBG concentration, and in addition may have an opposing effect on circulating thyroid hormone concentrations.
Article
Normal thyroid function is essential for development, growth, and metabolic homeostasis. The prerequisites for an euthyroid metabolic state include a normally developed thyroid gland, a properly functioning system for thyroid hormone synthesis, and sufficient iodine intake. Defects in any of the essential steps in thyroid development or thyroid hormone synthesis may result in morphologic abnormalities and impaired hormonogenesis. These defects can be partial or complete, leading to varying degrees of hypothyroidism. Morphologic alterations associated with congenital hypothyroidism include the absence of detectable thyroid tissue, ectopic tissue, thyroid hypoplasia, or a goitrous thyroid. However, in some patients with hypothyroidism, the thyroid is of normal size. This article focuses on defects in thyroid development. Recent insights into the developmental regulation of the calcitonin-producing C cells will not be discussed, and defects in hormone synthesis are discussed in an accompanying article.